Opinion: Preprints in the Public Eye

ASAPbio has developed resources for preprint servers, institutions, scientists, and journalists to promote the responsible reporting of research in the media.

Written byJigisha Patel
| 4 min read
asapbio preprints in the public eye media journalism science covid-19 sars-cov-2 pandemic coronavirus reporting newspaper tv

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

ABOVE: © ISTOCK.COM, JENNY ON THE MOON

The COVID-19 pandemic has had a profound effect on the growth of preprints. For scientists and health professionals, the pandemic has driven the need to share research findings about COVID-19, however preliminary, as quickly as possible to better understand its pathology, find new therapeutic options, and inform policy. Public demand for information about COVID-19 has driven the increase in media reporting of research posted as preprints. Even before the pandemic, there was a call for scientists to better understand the work of journalists, and the pandemic has made bridging the gap between the scientific and media communities, particularly in relation to communicating scientific uncertainty, an imperative.

Last year, ASAPbio conducted the #bioPreprints2020 questionnaire, an online survey of a wide range of stakeholders, including librarians, researchers, journalists, and funders, to understand perceived benefits and concerns about preprints. ASAPbio (Accelerating Science and Publication in biology) ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies